Cargando…
MUC4, MUC16, and TTN genes mutation correlated with prognosis, and predicted tumor mutation burden and immunotherapy efficacy in gastric cancer and pan‐cancer
Autores principales: | Yang, Yue, Zhang, Jieyun, Chen, Yanxing, Xu, Ruihua, Zhao, Qi, Guo, Weijian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7443139/ https://www.ncbi.nlm.nih.gov/pubmed/32898332 http://dx.doi.org/10.1002/ctm2.155 |
Ejemplares similares
-
Mutation of MUC16 Is Associated With Tumor Mutational Burden and Lymph Node Metastasis in Patients With Gastric Cancer
por: Zhang, Fengxiang, et al.
Publicado: (2022) -
Comprehensive characterization of MUC16 mutations in lung adenocarcinoma for immunotherapies and prognosis: An observational study
por: Liu, Tingjun, et al.
Publicado: (2023) -
Overexpression of MUC16 predicts favourable prognosis in MUC16-mutant cervical cancer related to immune response
por: Wang, Hao, et al.
Publicado: (2020) -
Bioinformatics Analysis Based on TCGA: MUC16 Mutation Correlates with Clinical Outcome in Gastric Cancer
por: Huang, Liang, et al.
Publicado: (2022) -
The role of MUC1 and MUC3 in the biology and prognosis of colorectal cancer
por: Duncan, Timothy J, et al.
Publicado: (2007)